每股分配比例：每 10 股派发现金股利 6.30 元（含税），公司不送红股， 不进行资本公积转增股本。 证券代码：688480 证券简称：赛恩斯 公告编号：2025-010 赛恩斯环保股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 2024 年度利润分配预案的公告 重要内容提示： 本次利润分配以实施权益分派股权登记日登记的总股本为基数，具体日 期将在权益分派实施公告中明确。 实施权益分派的股权登记日前公司总股本发生变动的，拟维持每股分配 金额不变，相应调整分配总额，并将另行公告具体调整情况。 公司未触及《上海证券交易所科创板股票上市规则》第 12.9.1 条第一款 第（八）项规定的可能被实施其他风险警示的情形。 一、利润分配方案内容 经天健会计师事务所（特殊普通合伙）审计，2024年公司实现归属于上市 公司普通股股东的净利润为180,757,969.30元。经董事会决议，公司2024年度 拟以实施权益分派股权登记日登记的总股本为基数分配利润。本次利润分配方 案如下： 公司拟向全体股东每10股派发现金红利6.3 ...

赛恩斯环保股份有限公司 关于 2023 年限制性股票激励计划部分限制性股票 作废失效的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 赛恩斯环保股份有限公司（以下简称"公司"）于 2025 年 4 月 23 日分别 召开第三届董事会第十七次会议和第三届监事会第十六次会议，审议通过《关 于 2023 年限制性股票激励计划部分限制性股票作废失效的议案》，具体情况如 下： 一、本激励计划已履行的决策程序和信息披露情况 （一）2023 年 3 月 20 日，公司召开第二届董事会第十九次会议，审议通 过《关于<2023 年限制性股票激励计划（草案）>及摘要的议案》《关于<2023 年限制性股票激励计划考核管理办法>的议案》《关于提请股东大会授权董事会 办理 2023 年限制性股票激励计划有关事项的议案》《关于提请召开 2023 年第 三次临时股东大会的议案》，公司独立董事发表了独立意见。 （二）2023 年 3 月 20 日，公司召开第二届监事会第十三次会议，审议通 过《关于<2023 年限制性股票激励计划（草案）>及摘要的议 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥170,297,088.13, representing a 63.46% increase compared to ¥104,184,107.78 in the same period last year[3] - The net profit attributable to shareholders decreased by 77.68% to ¥17,725,068.02 from ¥79,420,238.21 year-on-year[3] - Basic and diluted earnings per share fell by 77.38% to ¥0.19 from ¥0.84 in the previous year[3] - Total operating revenue for Q1 2025 reached ¥170,297,088.13, a 63.4% increase from ¥104,184,107.78 in Q1 2024[16] - Net profit attributable to shareholders of the parent company for Q1 2025 was ¥17,725,068.02, a decrease of 77.7% compared to ¥79,420,238.21 in Q1 2024[18] - Basic earnings per share for Q1 2025 was ¥0.19, down from ¥0.84 in Q1 2024[19] - The company reported a total comprehensive income of ¥20,410,532.73 for Q1 2025, down from ¥80,856,749.26 in Q1 2024[19] Research and Development - Research and development expenses totaled ¥11,535,438.40, an increase of 69.25% from ¥6,815,638.47 in the same period last year[3] - The proportion of R&D expenses to operating revenue increased by 0.23 percentage points to 6.77% from 6.54%[4] Cash Flow - The net cash flow from operating activities was negative at -¥52,181,166.86, compared to -¥22,550,454.83 in the same period last year, indicating increased cash outflows[3] - Cash inflow from operating activities in Q1 2025 totaled ¥199,871,436.70, compared to ¥159,174,110.84 in Q1 2024, reflecting a 25.6% increase[22] - Cash outflow from operating activities for Q1 2025 was ¥252,052,603.56, an increase from ¥181,724,565.68 in Q1 2024[22] - The net cash flow from operating activities was -$52.18 million, compared to -$22.55 million in the previous period[23] - The net increase in cash and cash equivalents was -$191.72 million, compared to -$312.99 million in the previous period[24] - The ending balance of cash and cash equivalents stood at $205.11 million, down from $220.38 million year-over-year[24] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,865,158,022.44, a 2.14% increase from ¥1,826,160,633.21 at the end of the previous year[4] - Current liabilities totaled RMB 634,739,278.23, compared to RMB 611,353,489.20, showing an increase of about 3.8%[14] - The company's long-term borrowings decreased to RMB 9,000,000.00 from RMB 14,000,000.00, a reduction of approximately 35.7%[14] - The total liabilities increased to RMB 643,739,278.23, compared to the previous period, indicating a growth trend in financial obligations[14] - The total liabilities as of the latest reporting period amounted to ¥729,691,085.25, compared to ¥712,184,376.33 in the previous period[15] Investment Activities - The company reported a significant decrease in investment income due to the previous year's acquisition of Fujian Zijinlong Chemical Co., which impacted net profit[6] - Cash inflow from investment activities totaled $208.64 million, down from $223.86 million year-over-year[23] - Cash outflow from investment activities was $353.49 million, a decrease from $515.52 million in the prior period[23] - Cash paid for investment activities was $336.72 million, slightly down from $340 million last year[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 3,586[8] - Total equity attributable to shareholders of the parent company was ¥1,094,516,967.20, an increase from ¥1,074,395,389.39[15]

Financial Performance - The company achieved a net profit attributable to ordinary shareholders of RMB 180,757,969.30 for the year 2024, with a proposed cash dividend of RMB 6.30 per 10 shares, totaling RMB 60,055,492.77, which represents 33.22% of the net profit [5]. - The company achieved operating revenue of CNY 927,193,355.37 in 2024, representing a 14.69% increase compared to CNY 808,404,965.99 in 2023 [22]. - Net profit attributable to shareholders reached CNY 180,757,969.30, a significant increase of 100.11% from CNY 90,327,937.30 in the previous year [25]. - The net cash flow from operating activities was CNY 66,674,122.30, showing a slight decrease of 0.96% compared to CNY 67,318,088.54 in 2023 [26]. - Total assets increased by 22.31% to CNY 1,826,160,633.21 at the end of 2024, up from CNY 1,493,018,387.90 at the end of 2023 [27]. - The net assets attributable to shareholders grew by 15.30% to CNY 1,074,395,389.39, compared to CNY 931,793,098.82 in the previous year [27]. - Basic earnings per share doubled to CNY 1.90 in 2024 from CNY 0.95 in 2023, reflecting a 100% increase [23]. - The company reported a quarterly revenue of CNY 342,402,067.80 in Q4 2024, contributing to the overall annual growth [29]. Research and Development - The R&D expenditure accounted for 6.10% of operating revenue, up from 5.67% in the previous year, indicating a focus on innovation [24]. - The total R&D expenses for the year reached ¥56,570,414.32, a 23.45% increase from ¥45,823,433.56 in the previous year [85]. - The increase in R&D expenses is primarily attributed to the acquisition of high-tech company Longli Chemical, leading to significant investments in R&D personnel and materials [86]. - The company is currently working on multiple R&D projects, with a total investment of ¥3,000 million across various initiatives [89]. - The company has developed advanced bio-agent products for heavy metal wastewater treatment, which significantly reduce operational costs and secondary pollution risks [96]. - The company has accumulated 139 intellectual property rights, including 60 invention patents, as of the end of the reporting period [81]. Business Strategy and Operations - The core business strategy is a "three-in-one" model, integrating technology, comprehensive solutions, and operational services for the non-ferrous metal industry and government departments [46]. - The company aims to be a leader in heavy metal pollution prevention, focusing on comprehensive solutions for wastewater, waste residue treatment, and resource utilization [45]. - The company plans to continue optimizing its business structure and increasing R&D investments to drive future growth [25]. - The company’s solutions are increasingly driving growth in product sales and operational services, creating a mutually beneficial ecosystem [46]. - The company has established a comprehensive service capability in heavy metal pollution prevention, integrating technology, products, production, and services into a unified operational system [98]. Market and Industry Trends - The heavy metal remediation market in China is expected to grow further due to stricter environmental policies and technological advancements [152]. - The heavy metal pollution prevention industry in China is transitioning from a fragmented to a concentrated market, with increasing barriers to entry and a focus on comprehensive service offerings [169]. - Companies with strong core technologies and R&D capabilities are expected to dominate the heavy metal pollution treatment market as regulatory pressures increase [170]. Governance and Compliance - The company has received a standard unqualified audit report from Tianjian Accounting Firm [4]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties [7]. - The company has not violated any regulatory decision-making procedures for external guarantees [7]. - The company has not experienced any situation where more than half of the directors cannot guarantee the authenticity, accuracy, and completeness of the annual report [8]. - The company emphasized the importance of accurate and timely disclosure of significant information to protect shareholder interests [189]. Financial Management - The company actively expanded financing channels, resulting in a net cash flow from financing activities of CNY 13,790,269.58, a significant increase compared to the previous year [119]. - The company has a significant accounts receivable balance, which poses operational cash flow risks if not managed properly [108]. - The gross profit margin in the environmental protection industry improved by 5.93 percentage points to 34.64% [120]. - The company benefits from tax incentives as a high-tech enterprise, but changes in tax policies could adversely affect its financial performance [110]. Subsidiaries and International Expansion - The company completed the acquisition of Longli Chemical, which is now a wholly-owned subsidiary, expanding its product offerings in mining reagents and extraction agents [127][128]. - The company is expanding its market presence through the establishment of subsidiaries in Serbia and Australia, indicating a strategic focus on international growth [162]. - The company has a total of 10 subsidiaries, including Sains Engineering and Longli Chemical, focusing on environmental technology and chemical production [156]. Future Outlook - In 2025, the company aims to achieve a balanced development across its three core strategic areas: environmental governance, resource recovery, and new materials, with a focus on product quality and operational excellence [173]. - The company will pursue both internal and external investment opportunities to support sustainable growth and enhance investor relations [180]. - The company aims to expand its market presence and optimize its business layout to promote high-quality sustainable development [182].

申万宏源证券承销保荐有限责任公司 关于赛恩斯环保股份有限公司 2025 年度公司及子公司申请综合授信额度并提供担保的核 查意见 一、担保情况概述 根据公司及长沙赛恩斯环保工程技术有限公司、宁乡东城污水处理有限公司、 福建紫金龙立化学有限公司、赛恩斯环保科技有限公司博尔市、西藏龙湘环保有 限公司（以下简称"子公司"）发展和资金需求，公司及子公司计划 2025 年度 拟向各大银行申请授信，授信额度用于办理经营所需的中长期项目贷款、短期流 动资金贷款、银行承兑、银行保函、银行保理、信用证、资金交易、进出口业务 项下的各种贸易融资等业务（包括但不限于履约担保、产品质量担保、并购贷产 品等）（具体业务品种由管理层根据经营需要与各银行协定）。本次计划申请的 授信额度合计为人民币 15 亿元（含本数），公司及子公司在上述综合授信额度 内相互提供担保，总金额不超过 3 亿元（含本数）。 二、子公司基本情况 （一）长沙赛恩斯环保工程技术有限公司 1、基本情况 | 项目 | 内容 | | --- | --- | | 公司名称 | 长沙赛恩斯环保工程技术有限公司 | | 统一社会信用代码 | 914301240985154665 ...

| | | | 一、审计报告……………………………………………………… 第 | 1—6 页 | | --- | --- | | 二、财务报表……………………………………………………… 第 7—14 | 页 | | （一）合并资产负债表…………………………………………… 第 | 7 页 | | （二）母公司资产负债表………………………………………… 第 | 8 页 | | （三）合并利润表………………………………………………… 第 | 9 页 | | （四）母公司利润表………………………………………………第 | 10 页 | | （五）合并现金流量表……………………………………………第 | 11 页 | | （六）母公司现金流量表…………………………………………第 | 12 页 | | （七）合并所有者权益变动表……………………………………第 | 13 页 | | （八）母公司所有者权益变动表…………………………………第 | 14 页 | | 三、财务报表附注……………………………………………… 第 15—110 | 页 | | 四、附件……………………………………………………… 第 111—114 | 页 | ...

申万宏源证券承销保荐有限责任公司 根据《证券发行上市保荐业务管理办法》、《上海证券交易所科创板股票上 市规则》等有关法律法规的规定，申万宏源证券承销保荐有限责任公司（以下简 称"申万宏源承销保荐"或"保荐机构"）作为赛恩斯环保股份有限公司（以下简称 "赛恩斯"、"公司"） 首次公开发行股票并在科创板上市持续督导阶段的保荐机 构，负责赛恩斯上市后的持续督导工作，并出具 2024 年度持续督导跟踪报告。 三、保荐机构和保荐代表人发现的问题及整改情况 无。 | 一、持续督导工作情况 | | --- | | 序 | 工作内容 | 持续督导工作情况 | | --- | --- | --- | | 号 | | | | 1 | 建立健全并有效执行持续督导工作制度， 并针对具体的持续督导工作制定相应的 | 保荐机构已建立健全并有效执行持续督导 | | | | 工作制度，并制定了相应工作计划 | | | 工作计划 | | | 2 | 根据中国证监会相关规定，在持续督导工 作开始前，与上市公司或相关当事人签署 | 保荐机构已与赛恩斯签订了保荐协议（明 | | | 持续督导协议，明确双方在持续督导期间 | 确双方在持续督导期间的权 ...

目 录 | | 二、附件………………………………………………………………第 | 3—6 | 页 | | --- | --- | --- | --- | | (一) | 本所营业执照复印件……………………………………… | 第 3 | 页 | | (二) | 本所执业证书复印件……………………………………… | 第 4 | 页 | | (三) | 签字注册会计师执业证书复印件………………………第 | 5—6 | 页 | 内部控制审计报告 天健审〔2025〕2-328 号 赛恩斯环保股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求，我 们审计了赛恩斯环保股份有限公司（以下简称赛恩斯公司）2024 年 12 月 31 日 的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》《企业内部控制应用指引》以及《企业内部 控制评价指引》的规定，建立健全和有效实施内部控制，并评价其有效性是赛恩 斯公司董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发表 审计意见，并对注意到的非财务报告内部控制的重大缺陷进行 ...

目 录 一、募集资金年度存放与使用情况鉴证报告………………………第 1—2 页 二、关于募集资金年度存放与使用情况的专项报告………………第 3—8 页 三、附件…………………………………………………………… 第 9—12 页 (一) 本所营业执照复印件……………………………………… 第 9 页 (二) 本所执业证书复印件………………………………………第 10 页 (三) 签字注册会计师执业证书复印件……………………第 11—12 页 募集资金年度存放与使用情况鉴证报告 天健审〔2025〕2-329 号 赛恩斯环保股份有限公司全体股东： 我们鉴证了后附的赛恩斯环保股份有限公司（以下简称赛恩斯公司）管理层 编制的 2024 年度《关于募集资金年度存放与使用情况的专项报告》。 一、对报告使用者和使用目的的限定 本鉴证报告仅供赛恩斯公司年度报告披露时使用，不得用作任何其他目的。 我们同意将本鉴证报告作为赛恩斯公司年度报告的必备文件，随同其他文件一起 报送并对外披露。 二、管理层的责任 赛恩斯公司管理层的责任是提供真实、合法、完整的相关资料，按照《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2 ...

申万宏源证券承销保荐有限责任公司 （三）投资产品品种 公司运用自有资金投资的品种为安全性高、流动性好的低风险理财产品。 为控制风险，以上额度内资金只能用于购买十二个月以内理财产品。 关于赛恩斯环保股份有限公司 使用自有闲置资金进行现金管理的核查意见 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"、"保 荐机构"）作为赛恩斯环保股份有限公司（以下简称"赛恩斯"、"公司"） 首次公 开发行股票并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》 《上海证券交易所科创板股票上市规则》和《上海证券交易所科创板上市公司自 律监管指引第1号——规范运作》等有关规定，对赛恩斯使用自有闲置资金进行 现金管理事项进行了审慎核查，发表核查意见如下： 一、使用自有资金购买理财产品的概况 （一）投资产品目的 为提高资金使用效率，合理利用自有资金，在不影响公司正常经营的情况 下，利用暂时闲置的自有资金进行理财产品投资，增加公司收益，为公司及股 东获取更多回报。 （二）投资产品额度 公司拟使用额度不超过人民币 1.5 亿元（含本数）进行理财产品投资，在 额度内可循环使用。 （四）投资行为授权期限 自公司第三届董 ...